Performance of [68Ga]Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer after prostatectomy-a multi-centre evaluation of 2533 patients.

Ali Afshar OmeriehMarcelo Livorsi da CunhaJairo WagnerUwe HaberkornNils DebusWolfgang WeberMatthias EiberTim Holland-LetzIsabel Rauscher

Published in: European journal of nuclear medicine and molecular imaging (2021)

[68Ga]Ga-PSMA-11 PET/CT at 1 h p.i. confirmed its high performance in the largest patient cohort yet analysed. Tumour detection showed a clear association with higher PSA and higher GSC. No association was found between a pathological [68Ga]Ga-PSMA-11 PET/CT and age, amount of injected tracer, PSADT or PSAVel.

Keyphrases

pet ct
prostate cancer
positron emission tomography
end stage renal disease
radical prostatectomy
newly diagnosed
chronic kidney disease
case report
prognostic factors
peritoneal dialysis
pet imaging
patient reported outcomes
quantum dots